Form 4 for ELVN Enliven Therapeutics, Inc.
Accepted 2023-12-21 00:00:00 ET · period of report 2023-12-19 · accession 0001209191-23-059431 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-12-21 | 2023-12-19+ | ELVN | Heyman Richard A. | Dir | S - Sale | $13.02 | -2,365 | 147.5K | -2% | -$30.8K |
| I | 2023-12-21 | 2023-12-20 | ELVN | Heyman Richard A. | Dir | S - Sale | $13.02 | -1,915 | 29.3K | -6% | -$24.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-19 | S | D | 255 | $13.00 | 149,565 | D See footnote | — | — | (F3) The shares are held of record by RAHD Capital LLC for which the Reporting Person serves as a managing member. |
| 2 | Common | Common Stock | 2023-12-20 | S | D | 1,915 | $13.02 | 29,257 | I | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $13.00 to $13.18. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Common Stock | 2023-12-20 | S | D | 2,110 | $13.02 | 147,455 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $13.00 to $13.18. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |